Alzheimer's Prevention Trial Targets Asymptomatic Individuals

A groundbreaking clinical trial is set to investigate the potential of an experimental drug to prevent Alzheimer's disease before symptoms manifest. The trial will enroll healthy middle-aged individuals identified as being at a higher risk of developing the condition.

This international effort, spearheaded by an NHS trust, aims to intervene in the early stages of Alzheimer's, targeting individuals who have not yet experienced memory loss or other cognitive impairments. By testing the drug on this asymptomatic group, researchers hope to determine if it can halt the disease's progression at its earliest molecular stages.